Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Arthritis & Rheumatism

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/art.24294PMID 19180495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reiter's syndrome: the classic triad and more.

  2008cited by this paper
• Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome.

  2008cited by this paper
• Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).

  2007cited by this paper
• Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

  2007cited by this paper
• Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

  2007cited by this paper
• Hereditary auto-inflammatory disorders and biologics

  2006cited by this paper
• Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.

  2006cited by this paper
• Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.

  2005cited by this paper
• Rab Proteins, Connecting Transport and Vesicle Fusion

  2005cited by this paper
• Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept

  2005cited by this paper
• Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.

  2004cited by this paper
• The genetic background of tumour necrosis factor receptor‐associated periodic syndrome and other systemic autoinflammatory disorders

  2004cited by this paper
• Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles.

  2004cited by this paper
• A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome

  2004cited by this paper
• Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction.

  2004cited by this paper
• Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

  2003cited by this paper
• Binding and functional comparisons of two types of tumor necrosis factor antagonists.

  2002cited by this paper
• Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.

  2001cited by this paper
• Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase.

  2001cited by this paper
• The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.

  2001cited by this paper
• Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages.

  2000cited by this paper
• Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

  1999cited by this paper
• Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram- negative sepsis

  1994cited by this paper

• Therapeutic Approaches for Periodic Fever Syndromes and Autoinflammatory Disorders.

  2025cites this paper
• Monogenic disorders of the TNF signalling pathway

  2025cites this paper
• Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells.

  2025cites this paper
• Targeted treatments for immune dysregulation in inborn errors of immunity

  2024cites this paper
• A patient with tumor necrosis factor receptor-associated periodic syndrome misdiagnosed as Kawasaki disease: A case report and literature review

  2023cites this paper
• Autoinflammatory Diseases/Periodic Fevers.

  2023cites this paper
• Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.

  2022cites this paper
• Neuroinflammation Associated With Inborn Errors of Immunity

  2022cites this paper
• Systemic Autoinflammatory Diseases: A Growing Family of Disorders of Overlapping Immune Dysfunction.

  2022cites this paper
• Inherited Autoinflammatory Syndromes.

  2021cites this paper
• TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS

  2021cites this paper
• Autoinflammatory syndromes

  2021cites this paper
• Autoinflammationssyndrome

  2021cites this paper
• TRAPS bei Kindern und Jugendlichen

  2021cites this paper
• Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network

  2021cites this paper
• Autoinflammatory Disorders

  2021cites this paper
• RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease.

  2020cites this paper
• Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives

  2020cites this paper
• Rheumatic Disease in Geriatrics: Diagnosis and Management

  2020cites this paper
• Monogenic autoinflammatory disorders: beyond the periodic fever

  2020cites this paper
• Systemic autoinflammatory diseases

  2020cites this paper
• Autoinflammatory Diseases in the Geriatric Population

  2020cites this paper
• Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)

  2020cites this paper
• IL-1 mediated autoinflammatory diseases

  2020cites this paper
• Rare Rheumatic Diseases of Immunologic Dysregulation

  2019cites this paper
• Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease.

  2019cites this paper
• Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor‐associated periodic syndrome

  2019cites this paper
• Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases

  2019cites this paper
• Tumor Necrosis Factor (TNF) Receptor-Associated Periodic Syndrome (TRAPS)

  2019cites this paper
• Hereditary Autoinflammatory Disorders: Recognition and Treatment.

  2019cites this paper
• TRAP1 chaperone protein mutations and autoinflammation

  2019influential citation
• La fièvre récurrente liée au récepteur 1 du TNF ( TNF receptor associated periodic syndrome – TRAPS)

  2018cites this paper
• A Comprehensive Overview of the Hereditary Periodic Fever Syndromes

  2018cites this paper
• Chapter 12 Immunotherapeutic Biologic Agents to Treat Autoinflammatory Diseases

  2018cites this paper
• TRAPS, síndrome periódico asociado al receptor de necrosis tumoral: inmunopatogénesis y enfoque clínico

  2018cites this paper
• [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].

  2018cites this paper
• Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.

  2018cites this paper
• Recurrent Fever Syndromes

  2018cites this paper
• Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report

  2017cites this paper
• Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient

  2017cites this paper
• Canakinumab for the treatment of TNF-receptor associated periodic syndrome

  2017cites this paper
• Therapeutic Antibody‐Based Drugs in the Treatment of Human Inflammatory Disorders

  2017cites this paper
• Canakinumab for the treatment of TNF-receptor associated periodic syndrome (TRAPS)

  2017cites this paper
• An Up-to-date Approach to a Patient with a Suspected Autoinflammatory Disease

  2017cites this paper
• Immunotherapeutic Biologic Agents to Treat Autoinflammatory Diseases

  2017cites this paper
• Tumor necrosis factor-associated periodic syndrome in adults

  2017cites this paper
• Hereditäre periodische Fiebersyndrome (HPFS)

  2016cites this paper
• Monogenic Auto-inflammatory Syndromes: A Review of the Literature.

  2016cites this paper
• Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

  2016cites this paper
• Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1‐associated periodic syndrome

  2016cites this paper
• Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists’ lens

  2016cites this paper
• Chapter 47 – Periodic Fever Syndromes and Other Inherited Autoinflammatory Diseases

  2016cites this paper
• Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation

  2016cites this paper
• Recurrent Fevers for the Pediatric Immunologist: It’s Not All Immunodeficiency

  2015cites this paper
• Laboratory Medicine to improve biological therapeutic treatment

  2015cites this paper
• Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

  2015cites this paper
• A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.

  2015cites this paper
• A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS)

  2014cites this paper
• Erkrankungen mit rezidivierenden Fieberschüben

  2014cites this paper
• Untangling the Web of Systemic Autoinflammatory Diseases

  2014cites this paper
• Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases

  2014cites this paper
• Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome

  2014cites this paper
• Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.

  2014cites this paper
• Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature.

  2014cites this paper
• Classic Autoinflammatory Diseases: Monogenic Autoinflammatory Diseases Caused by Defects in CIAS1, MEFV, TNFRSF1A, MVK, and PSTPIP1

  2014cites this paper
• Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.

  2013cites this paper
• Introduction to autoinflammatory syndromes and diseases.

  2013cites this paper
• Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes.

  2013cites this paper
• The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review.

  2013cites this paper
• Autoinflammation: From monogenic syndromes to common skin diseases.

  2013cites this paper
• Monogenic autoinflammatory diseases: concept and clinical manifestations.

  2013cites this paper
• Genetische Fiebersyndrome

  2013cites this paper
• Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders

  2013cites this paper
• Novedades en el diagnóstico y tratamiento del síndrome periódico asociado al receptor del factor de necrosis tumoral

  2013cites this paper
• Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS).

  2013cites this paper
• Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues

  2013cites this paper
• Makrophagen-Aktivierungssyndrom als initiale Manifestation eines Tumornekrosefaktor-Rezeptor-1-assoziierten periodischen Syndroms (TRAPS)

  2013cites this paper
• Syndromes and Diseases

  2013cites this paper
• Genetische Fiebersyndrome Hereditäre rekurrierende (periodische) Fiebersyndrome

  2013cites this paper
• Inflammasome and cytokine blocking strategies in autoinflammatory disorders.

  2013cites this paper
• Biologic drugs in autoinflammatory syndromes.

  2012cites this paper
• Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome

  2012cites this paper
• Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives.

  2012cites this paper
• Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

  2012cites this paper
• The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.

  2012cites this paper
• The autoinflammatory diseases.

  2012cites this paper
• Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases

  2012cites this paper
• Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.

  2012cites this paper
• Typical and severe tumor necrosis factor receptor–associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series

  2012cites this paper
• Tumor necrosis factor receptor associated periodic fever syndrome with photographic evidence of various skin disease and unusual phenotypes: case report and literature review.

  2012cites this paper
• Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

  2012cites this paper
• A Glance at History and Future Perspectives of Childhood Autoinflammatory Disorders

  2012cites this paper
• Best Practice & Research Clinical

  2012cites this paper
• Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion

  2011cites this paper
• Hereditary recurrent fevers

  2011cites this paper
• Functional consequences of disease-associated mutations in TNFR1 elucidated by transcriptome analysis.

  2011cites this paper
• A clinical perspective of IL‐1β as the gatekeeper of inflammation

  2011cites this paper
• Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A.

  2011cites this paper
• TNF alpha antagonist therapy and safety monitoring.

  2011cites this paper
• Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome

  2011cites this paper